Walker Neuro Lab

Neurodegeneration Pathobiology Lab studying TDP-43, on a mission to cure #MND #ALS & #FTD. Led (and most tweets) by @adamkeithwalker. @QldBrainInst, @UQ_News.

[Walker Neuro Lab @WalkerNeuroLab]

Very happy to see our collaborative project led by @Rebecca_SanGlia with @adamkeithwalker out today in @NatureComms, tracking proteomic changes in the cortex throughout disease in TDP-43 mice with comparison to human #ALS #FTD https://t.co/OuOCErpvXb

[Rebecca San Gil @Rebecca_SanGlia]

TDP-43-mediated neurodegeneration is complex. We show that prior to disease onset in a mouse model of ALS/FTD, cortex neurons elicit a transient increase in protective chaperones that combat TDP-43 aggregation. Read it @NatureComms:
https://t.co/5j1fnltGRV

[Dehorter Lab @DehorterLab]

The @dehorterlab is excited to share a new study demonstrating a causal link between #immune activation, #alphasynuclein and #Parkinson onset.
This work establishes the first immune-induced model to investigate the prodromal phase of idiopathic #Parkinson.
@QldBrainInst @JCSMR

[Natalie Farrawell @NatalieFarrawe1]

Today would have been Justin's 50th birthday, but as many of you know, Justin passed away last year after a long battle with MND
This weekend the Yerbury lab are taking part in the walk to defeat MND to raise vital funds to support those living with MND ⬇️
https://t.co/UxXuf5qsJm

[James Vickers @JamesCVickers]

Excellent piece on frontotemporal dementia by @AmyBrodtmann.

[MND Research Australia @MND_RIA]

SAVE THE DATE!
We will be holding the 3rd Australian and New Zealand MND Research Symposium in Melbourne on Tuesday 27th and Wednesday 28th of August.
An MND Connect session will also run on the Wednesday.

Further information to come as we progress with the event.

[Walker Neuro Lab @WalkerNeuroLab]

This is sad news on the outcomes of the pivotal phase 3 trial of AMX0035, which did not meet any of the primary or secondary outcome measures for people living with ALS/MND. Next steps unclear, but there are many more treatments in testing which will hopefully be more positive.

[Amylyx @AmylyxPharma]

Today, we shared the topline results from our Phase 3 PHOENIX trial. Read more in our press release: https://t.co/3aUL97sVdo

On behalf of the entire Amylyx team, we are grateful to the ALS community and for the dedication of trial participants, investigators, and study site teams. With data collected from 664 participants in PHOENIX, we are certain there will be important learnings that will help inform future ALS research.

[Ethan Perlstein 1-to-N @eperlste]

Trikafta — a triple small molecule combo therapy — can be considered functionally curative, though variant specific top-ups are still in play.

More of this please!

[The Rainwater Charitable Foundation @RCFNeuro]

World-renowned scientist Dr. Virginia Man-Yee Lee at @PennMedicine has made groundbreaking contributions to our understanding of tau, earning her the 2024 #RainwaterPrize for Outstanding Innovation in Neurodegenerative Research, to be awarded at #Tau2024. https://t.co/WohawyNHPq

[Queensland Brain Institute, UQ @QldBrainInst]

"We found several proteins that were driving disease forward and making it worse... we also found proteins that are increased early in disease and are protective."

@QldBrainInst researcher @Rebecca_SanGlia explains how her protein map could offer therapeutic pathways for #MND.

[Walker Neuro Lab @WalkerNeuroLab]

This work first initiated with support from @MND_RIA, and with vital further support from @FightMND, @racingdementia, @DementiaAus along with @nhmrc and fantastic donors to @QldBrainInst - our research couldn’t be done without it.

[Walker Neuro Lab @WalkerNeuroLab]

Very happy to see our collaborative project led by @Rebecca_SanGlia with @adamkeithwalker out today in @NatureComms, tracking proteomic changes in the cortex throughout disease in TDP-43 mice with comparison to human #ALS #FTD https://t.co/OuOCErpvXb

[Rebecca San Gil @Rebecca_SanGlia]

TDP-43-mediated neurodegeneration is complex. We show that prior to disease onset in a mouse model of ALS/FTD, cortex neurons elicit a transient increase in protective chaperones that combat TDP-43 aggregation. Read it @NatureComms:
https://t.co/5j1fnltGRV

[Walker Neuro Lab @WalkerNeuroLab]

Kicking goals @elise_kellett!

[MND Research @PremiumXRemark]

Toxic clumps of a protein called TDP-43 are found in 97% of #MND #ALS cases.🔬

Elise Kellett has shown that toxic TDP-43 can stop other proteins from working correctly.

Investigation of the specific pathways affected could lead to new treatments.⬇️

https://t.co/arkl6YSuvj

[Walker Neuro Lab @WalkerNeuroLab]

Congrats @elise_kellett - doing the lab proud!

[Queensland Brain Institute, UQ @QldBrainInst]

Congratulations to @elise_kellett, who received the Joan Lawrence Endowment Prize for High Achieving Women in Neuroscience. 💜

Elise is currently doing her #PhD in the @WalkerNeuroLab at the @QldBrainInst, researching potential therapeutic interventions in Motor Neuron Disease.

[Queensland Brain Institute, UQ @QldBrainInst]

Congratulations to @elise_kellett, who received the Joan Lawrence Endowment Prize for High Achieving Women in Neuroscience. 💜

Elise is currently doing her #PhD in the @WalkerNeuroLab at the @QldBrainInst, researching potential therapeutic interventions in Motor Neuron Disease.

[Walker Neuro Lab @WalkerNeuroLab]

Just out - Jane Simpson has a chat with @adamkeithwalker about MND research and why there is cause for hope, on Jane's new podcast 'Let's Talk MND' https://t.co/rTe6J6dQjq

[Trends in Neurosciences @TrendsNeuro]

@TrendsNeuro 'Spotlight' by Matisse Jacobs, Rebecca San Gil & Adam Walker @WalkerNeuroLab
https://t.co/8CeMVXsQgk

discussing Guo et al. 2023 ‘Disruption of ER ion homeostasis maintained by an ER anion channel CLCC1 contributes to ALS-like pathologies’
https://t.co/SndzlXx6Ux

[FrattaLab @FrattaLab]

Want to deliver gene therapies broadly, but activate them only in diseased neurons?
TDP-REG "hacks" TDP cryptic mis-splicing to drive expression only WHEN and WHERE needed! Less toxicity, wider therapeutic window, new options for sporadic ALS therapies.
https://t.co/VWvioiXmAN

[Walker Neuro Lab @WalkerNeuroLab]

Thank you to @FightMND and all the supporters for giving a thumbs up to our new collaborative project @QldBrainInst with @adamkeithwalker @samkbarton7 @Rebecca_SanGlia @DrCarlieCullen @DrCathBlizzard and co! We are eager to get started!

[FightMND @FightMND]

Introducing our third grant recipient of 2023, Dr. @adamkeithwalker from @UQscience. His project ‘Oligodendrocytes and TDP-43 pathology in MND' aims to unlock the causes and disease mechanisms of MND. We're so lucky to support the best and brightest researchers in Aus.

[FightMND @FightMND]

Join us on 24 October at 12pm AEDT to hear about how patient registries are helping to accelerate clinical discoveries in MND research.

Register at: https://t.co/7ITaphY74k

[Todd Cohen @ToddCohen27]

Super proud of @JulieNecNeuro for the long journey and the massive amount of work that went into this paper. You will be missed!

[Walker Neuro Lab @WalkerNeuroLab]

Abstracts closing Oct 5 for the conference on cellular and molecular neurodegeneration #CAMAND23, to be @QldBrainInst on Dec 3-4, 2023! https://t.co/oH21ifvl0d

Prizes and travel awards for students and ECRs - get in quick!

[CAMAND @CAMAND_Neuro]

Last chance to get your abstracts in for #CAMAND23 conference!!

Only 2 days before abstract submission closes

Submit at https://t.co/z82uPKlCxi by 5pm, Thursday Oct 5th

@DrEleanorD @DannyHatters @MargaretSunde @anthonyjhannan